REG-BARCLAYS PLC Form 8.3 - National Express Group plc
24/01/2022 13:35
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220124:nBw686rQta&default-theme=true
Form 8.3 - National Express Group plc
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose NATIONAL EXPRESS GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 21 January 2022
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? STAGECOACH GROUP PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 523,398 0.09% 10,499,584 1.71%
(2) Cash-settled derivatives:
10,023,739 1.63% 255,823 0.04%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 10,547,137 1.72% 10,755,407 1.75%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other
employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
5p ordinary Purchase 21 2.6418 GBP
5p ordinary Purchase 52 2.6480 GBP
5p ordinary Purchase 576 2.6567 GBP
5p ordinary Purchase 615 2.6317 GBP
5p ordinary Purchase 2,200 2.6557 GBP
5p ordinary Purchase 2,205 2.6432 GBP
5p ordinary Purchase 2,920 2.6311 GBP
5p ordinary Purchase 4,487 2.6362 GBP
5p ordinary Purchase 5,221 2.6476 GBP
5p ordinary Purchase 5,837 2.6437 GBP
5p ordinary Purchase 10,525 2.6390 GBP
5p ordinary Purchase 24,757 2.6396 GBP
5p ordinary Purchase 30,240 2.6400 GBP
5p ordinary Purchase 38,921 2.6388 GBP
5p ordinary Purchase 40,635 2.6470 GBP
5p ordinary Sale 1 2.6380 GBP
5p ordinary Sale 97 2.6410 GBP
5p ordinary Sale 104 2.6462 GBP
5p ordinary Sale 456 2.6440 GBP
5p ordinary Sale 899 2.6432 GBP
5p ordinary Sale 1,052 2.6300 GBP
5p ordinary Sale 1,121 2.6603 GBP
5p ordinary Sale 2,200 2.6558 GBP
5p ordinary Sale 2,219 2.6401 GBP
5p ordinary Sale 2,920 2.6312 GBP
5p ordinary Sale 3,044 2.6299 GBP
5p ordinary Sale 4,324 2.6318 GBP
5p ordinary Sale 10,525 2.6390 GBP
5p ordinary Sale 28,725 2.6403 GBP
5p ordinary Sale 29,032 2.6329 GBP
5p ordinary Sale 46,359 2.6323 GBP
5p ordinary Sale 189,270 2.6400 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
5p ordinary SWAP Long 2,172 2.6320 GBP
5p ordinary SWAP Long 2,426 2.6280 GBP
5p ordinary SWAP Long 3,044 2.6299 GBP
5p ordinary CFD Long 4,282 2.6296 GBP
5p ordinary SWAP Long 4,500 2.6422 GBP
5p ordinary SWAP Long 11,292 2.6353 GBP
5p ordinary SWAP Long 15,568 2.6313 GBP
5p ordinary SWAP Long 17,753 2.6324 GBP
5p ordinary SWAP Long 27,369 2.6400 GBP
5p ordinary SWAP Long 30,641 2.6335 GBP
5p ordinary CFD Long 145,728 2.6400 GBP
5p ordinary CFD Short 115 2.6363 GBP
5p ordinary SWAP Short 312 2.6362 GBP
5p ordinary SWAP Short 1,280 2.6573 GBP
5p ordinary SWAP Short 1,453 2.6428 GBP
5p ordinary SWAP Short 1,453 2.6433 GBP
5p ordinary CFD Short 3,635 2.6402 GBP
5p ordinary SWAP Short 3,941 2.6445 GBP
5p ordinary SWAP Short 5,275 2.6400 GBP
5p ordinary SWAP Short 6,154 2.6567 GBP
5p ordinary SWAP Short 7,245 2.6405 GBP
5p ordinary SWAP Short 7,828 2.6407 GBP
5p ordinary SWAP Short 10,766 2.6385 GBP
5p ordinary SWAP Short 16,442 2.6367 GBP
5p ordinary SWAP Short 29,206 2.6462 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state
“none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 Jan 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be
included, provided contact information has been provided to the Panel’s
Market Surveillance Unit.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk/) .
View source version on businesswire.com:
https://www.businesswire.com/news/home/20220124005430/en/
(https://www.businesswire.com/news/home/20220124005430/en/)
BARCLAYS PLC
Copyright Business Wire 2022Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement